In the TME, cancer cell-derived ligands of VEGF receptor (VEGFR-)3 (VEGF-C, VEGF-D, and VEGF-A) can induce lymphangiogenesis, the equivalent of blood vessel angiogenesis that leads to the sprouting and attraction of LVs37,38. Here, VEGFD is linked to cancer.